The PennZone

  • Home
  • Business
  • Health
  • Non-profit
  • Financial
  • Education
  • Technology
  • Entertainment
  • Construction

Solomon Eye Appoints Dr. Nancy Draskovic as Clinical Director of Ocular Surface Disease
The PennZone/10305267

Trending...
  • Live Good Relaunches "Be The Generation" Initiative to Empower Student Leadership Amid Cuts to Public Health and Education
  • JERSEY GIRL HOT SAUCE Naturally Bold. Unintentionally Life-Changing
  • Bluumly Chosen as Finalist for the 2025 MIT Sloan CIO Symposium's Innovation Showcase
Solomon Eye
BOWIE, Md. - PennZone -- Solomon Eye Physicians and Surgeons is proud to announce the promotion of Dr. Nancy Draskovic to Clinical Director of Ocular Surface Disease, a new leadership role created to advance the organization's commitment to clinical excellence and innovation in patient care.

Dr. Draskovic joined Solomon Eye in 2017 and has consistently demonstrated exceptional expertise in the diagnosis and management of complex ocular conditions. Her collaborative approach, dedication to patient outcomes, and passion for education have made her an invaluable asset to both patients and colleagues alike.

In this new role, Dr. Draskovic will lead the clinical strategy for the Ocular Disease division, supporting best-in-class protocols, mentoring clinical staff, and driving continued advancement in treatment options for conditions such as dry eye, glaucoma, macular degeneration, and diabetic eye disease.

More on The PennZone
  • Global Patient Organizations Applaud Historic Passage of Integrated Lung Health Resolution at World Health Assembly 78
  • Squirrel Hill small business LabNaturals launches new streamlined online shopping experience just in time for its annual Memorial Day Sale
  • Love, Laughter, And Legacy Collide In The Romantic Comedy "different With Me"
  • Natalie Jean Releases Heartfelt Tribute Single "What They Didn't See" Honoring Late Friend and Lyricist Michael Peloso
  • Business Funding Assist Significantly Expands Funding Solutions, Empowering Businesses Across the U.S. and Canada

"Dr. Draskovic's promotion reflects both her outstanding clinical leadership and our continued focus on delivering top-tier, patient-centered care," said Dr. Jonathan Solomon, Medical Director at Solomon Eye. "She brings the perfect balance of experience, innovation, and compassion to this role."

Dr. Draskovic holds her Doctor of Optometry from The New England College of Optometry with residency training at the Baltimore VA Medical Center focused on ocular disease. She is an active member of the American Academy of Optometry and frequently lectures on advancements in disease management and interdisciplinary care.

"I'm honored to take on this position and work alongside a team so deeply committed to improving the lives of our patients," said Dr. Draskovic. "Together, we'll continue to raise the standard of care in our community."

For more information about Solomon Eye Physicians and Surgeons and its full range of services, visit www.solomoneye.com.

Contact
Rebecca Hartman
***@solomoneye.net


Source: Solomon Eye

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • 150% Increase in Fiscal Q2 Sales vs Previous Year to $750,000; Continuous Record Quarters & Profitability for Homebuilding Product: Innovative Designs
  • Jonathan Grode Named on 2025 Pennsylvania Super Lawyers List for Immigration Law
  • Use Dogecoin (DOGE) to mine Bitcoin (BTC) and earn passive income at home
  • Viatris to Participate in Upcoming Investor Conferences
  • European Tech Startup RoarFun discovers a gap in the U.S. market with a branded racing simulator rental at Atlanta's MRO Americas Aviation Convention
  • Degrees of Justice: Attorney Frank Walker Charts the Future of Criminal Justice with Ph.D Degree
  • The Jesse Roldan Team and Biz Hub Financial Successfully Facilitate One-Day Closing for Investor Deal in Hellertown, PA
  • How Does Google Crawl Websites?
  • Perspectives: Jellyfish Publication of an exciting new human clinical trial of proprietary KollaJellâ„¢ collagen peptide formulation
  • Historic Train Station Becomes Columbia Grand, Phoenixville's New Event & Wedding Venue
  • Sequentex Achieves OMNIA Partners Approval, Empowering Public Sector and other Agencies with Streamlined Technology Procurement
  • CEO Selected to Present at Wall Street Conference on May 21, 2025 for Suicidal Depression / PTSD: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
  • $10 Million Plan to Acquire Successful Remote Lottery Platform: Expanding Global Footprint into Live Entertainment: Lottery.com (Stock Symbol: LTRY)
  • Assent Launches Carbon Border Adjustment Mechanism Solution to Help Manufacturers Meet Regulatory Requirements
  • Q1 2025 Revenue Soars 92% to $1.13M on Strategic Acquisitions, Organic Growth & Breakthroughs in AI Drones & Quantum Tech: ZenaTech Stock Symbol: ZENA
  • STRETCH ZONE CELEBRATES GRAND OPENING IN WEST READING, PA
  • Savista Retreat Announces Monthly Yoga, Wellness & Experiential Retreats in Jaipur
  • Robert Tsigler Selected by NADC as Top 1% Attorney in the U.S. for 2025
  • **Award-Winning Dystopian Book Series Hitting Too Close to Home**
  • Neoware Unveils Strategic Transformation as a Specialist "Data to Intelligence" Partner

Popular on PennZone

  • Seecoin Expands Beyond Gaming: A Web3 (r)evolution for All Content Creators - 110
  • Sober.Buzz the Sober Token : Ticker $BUZZ - 107
  • Cybersecurity is Protecting Your Personal Information and Your Portfolio - 106
  • ImagineX, in Collaboration with Qualys, Launches New mROC Services to Transform Enterprise Cyber Risk Management - 104
  • UIFCA Revolutionizes Financial Education with Elite Team of Investment Experts - 103
  • DuoKey to Unveil Encrypted Financial Intelligence Use Case at GISEC Global 2025 - 102
  • Is Billboard Advertising Still Effective in 2025?
  • Rkaydz Video Game Museum Launches "Acquisition Series"
  • L2 Aviation Celebrates Grand Opening of New Facility at Cincinnati/Northern Kentucky International Airport (CVG)
  • $56.7 Million Announced in Q1 2025 with Revenue Growth and Progress Toward NASDAQ Uplisting for AI Marketing Company: IQSTEL, Inc. Stock Symbol: IQSTD

Similar on PennZone

  • Mental Health Watchdog Calling for a Ban on the Use of the Electroshock Machine in Florida
  • CEO Selected to Present at Wall Street Conference on May 21, 2025 for Suicidal Depression / PTSD: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
  • Phoenix Implant Clinic Introduces Upfront Cost Page to Strengthen Patient Trust
  • Pregis Expands its Curbside-Recyclable Paper Packaging Portfolio with White EasyPack GeoTerra
  • Advanced Dental Techniques Recognized as a Top Family Dentist for 2024
  • Solomon Eye Physicians & Surgeons announces appointment of Ann Reiling as Chief Operations Officer
  • APA Faces Outrage: Child Deaths and a $329 Billion Mental Health Failure
  • Koplon Implant & Family Dentistry Receives National Recognition as One of the Best Dental Implant Practices in the U.S
  • $7.8M Financing Boosts NRx's Expansion with Kadima Institute Acquisition for PTSD and Depression Care: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us